Artificial intelligence and cholangiocarcinoma: Updates and prospects

Hossein Haghbin1, Muhammad Aziz2

  • 1Department of Gastroenterology, Ascension Providence Southfield, Southfield, MI 48075, United States. hoshaq@yahoo.com.

Summary

Artificial intelligence (AI) can improve diagnosis, treatment, and prognosis for cholangiocarcinoma (CCA), a liver cancer. While AI shows great potential, more research is needed on its real-world impact on patient survival.